{"disease":{"id":"tumor-induced-osteomalacia","name":"tumor induced osteomalacia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00024804","title":"A Natural History Study of Bone and Mineral Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Institute of Dental and Craniofacial Research (NIDCR)","has_results":false},{"nct_id":"NCT04689893","title":"Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07366099","title":"Al18F-NOTA-LM3 PET/CT in Patients With TIO","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04783428","title":"Tumor-induced Osteomalacia Disease Monitoring Program","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":23,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT02304367","title":"Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Kyowa Kirin, Inc.","has_results":true},{"nct_id":"NCT05357573","title":"Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT03510455","title":"BGJ398 for the Treatment of Tumor-Induced Osteomalacia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"National Institute of Dental and Craniofacial Research (NIDCR)","has_results":true},{"nct_id":"NCT03775187","title":"Expanded Access to Burosumab","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}